COSA 2021: Niraparib Confers Longer PFS in BRCA-Mutated Ovarian Cancer
Results of three phase 3 trials were summarized.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Results of three phase 3 trials were summarized.
Only registered members have full access to PracticeUpdate content.